The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia

To improve the outcome of children with acute lymphoblastic leukemia (ALL) treated at the National Cancer Institute, Bogota, Colombia, a protocol based on the BFM-90 (Berlin, Frankfurt, Munster study) and the LSA2L 2 regimens was implemented in the year 1993. The patients were classified as being st...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2008

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22419

Acceso en línea:

https://doi.org/10.1097/MPH.0b013e31817e4a7d
https://repository.urosario.edu.co/handle/10336/22419

Palabra clave:

Antineoplastic agent
Asparaginase
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Folinate calcium
Mercaptopurine
Methotrexate
Prednisone
Acute lymphoblastic leukemia
Adolescent
Article
Cancer chemotherapy
Cancer mortality
Cancer radiotherapy
Cancer regression
Cancer relapse
Cancer risk
Cancer survival
Central nervous system
Child
Colombia
Controlled study
Cytogenetics
Drug dose reduction
Drug megadose
Female
Human
Infant
Major clinical study
Male
Multiple cycle treatment
Preschool child
Priority journal
School child
Treatment outcome
Treatment response
Adolescent
Antineoplastic combined chemotherapy protocols
Central nervous system neoplasms
Child
Cohort studies
Colombia
Cranial irradiation
Cytogenetic analysis
Humans
Infant
Precursor cell lymphoblastic leukemia-lymphoma
Prednisone
Recurrence
Remission induction
Risk
Survival rate
Cns-leukemia
Developing country
Intensive chemotherapy
Pediatric all
preschool
Child

Rights

License

Abierto (Texto Completo)